This is how the Install App dialog will look like once your App goes live.
THE OPHTHALMIC JOURNALDid you notice 2022 go by?
It’s been a whirlwind of a year, punctuated by COVID restrictions, conferences and a changing guard. Same, same, but different, you might say.
There have been highlights – among them the much anticipated arrival of innovative products like Hoya’s MiyoSmart and Essilor’s Stellest lenses for myopia, Roche’s Vybysmo for wet age-related macular degeneration, and a penguin in New Zealand that made full recovery following cataract surgery.
There have been low moments – among them the passing of three great contributors to eye health in Australia – Dr Con Moshegov, Richard Grills and most recently, Professor Brian Layland.
There has been significant change in leadership in key organisations guiding eye health: RANZCO, Glaucoma Australia, Macular Disease Foundation Australia, Optometry Australia, ProVision, and Vision 2020. And of course, Australia’s Health Minister with the change of federal government.
At mivision we’ve also had a year of growth and change, with Maren Carson joining us as Head of Partnerships and Michelle Hauschild returning to write. We’ve farewelled Emily Gibbs, who has taken the next step in her career. Our journal has continued to grow and is now, on average, 132 pages each month. Our CPD offering is increasingly sought out by optometrists, both in Australia and overseas.
We couldn’t achieve all of this without the expert ophthalmologists, optometrists and academics who generously share their expertise each month. This enables us to consistently publish articles that inform, educate, and promote collaborative health care with the ultimate aim of always improving patient outcomes.
Thank you to our contributors, our readers, and our advertisers. And thank you to the incredible team at mivision who work tirelessly and support each other ferociously, through change and challenge, to get mivision out.
I wish you all the best for the festive season.
Enjoy this issue. We look forward to bringing you more in 2023.
MELANIE KELL EDITORIn the spirit of reconciliation, mivision acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today. As a bi-national publication, we acknowledge Māori as tangata whenua and Treaty of Waitangi partners in Aotearoa New Zealand.
contributorsOPHTHALMOLOGISTSAssociate Professor Chameen Samarawickrama is a clinician-scientist, named one of the Top 5 Young Scientists of 2019 by the ABC. He holds an NHMRC Investigator Fellowship and is head of the Translational Ocular Research and Immunology Consortium, based at the Westmead Institute for Medical Research.
Dr Samantha Lee Professor David MackeyOPTOMETRISTSDr Celine Zhang has a special interest in paediatric optometry, vision therapy, myopia control, dry eye and therapeutic management of ocular disease. After winning awards in University, she completed an internship alongside renowned ophthalmologists in OMNI Eye Services New York and New Jersey, where she gained knowledge of surgical and advanced therapeutic treatments for eye disease.
Dr Ben Ashby Wes Butler Philip Cheng Jessica Chi Narelle Hine Jagrut Lallu Claire Mallon Hannah Maher Dr SooJin Nam Alan Saks Oliver WooPROFESSION INFLUENCERSUlli Hentschel, the Training and Development Manager for Hoya Lens Australia, has led the introduction of MiyoSmart into the Australian and New Zealand markets. He works closely with global and local key opinion leaders in myopia management as well as other industry leaders to drive the topic of myopia